BRIEF-Biomarin Pharmaceutical Q3 EPS USD -0.63
Reuters2026/11/02 21:04Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!
A welcome pack worth 6200 USDT for new users! Sign up now!
Nov 02 (Reuters) - Biomarin Pharmaceutical Q3 revenue USD 1,025 million vs. IBES estimate USD 1,026 million.
- Q3 net income USD -123 million
- Q3 adjusted EPS USD 0.23 vs. IBES estimate USD 0.12
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now！
You may also like
Meridian weighs $400 million investment decision for Cabaçal mine
Mining.com•2026/11/09 17:18
Charles Schwab Adds Solana, Avalanche and Chainlink to Crypto Trading Platform
Coinedition•2026/11/09 17:15
Innovative Eyewear Q3 revenue rises sequentially on sales volume
Reuters•2026/11/09 17:04
Crypto prices
More
Bitcoin
BTC
$74,691.84
-1.30%
Ethereum
ETH
$2,122.54
-4.71%
Tether USDt
USDT
$0.9991
+0.04%
BNB
BNB
$685.34
-1.39%
USDC
USDC
$0.9999
+0.02%
XRP
XRP
$1.09
-5.25%
Solana
SOL
$86.44
-2.81%
TRON
TRX
$0.3170
-0.91%
Zcash
ZEC
$1,167.18
-6.41%
Hyperliquid
HYPE
$74.74
-2.27%
How to buy BTC
Bitget lists BTC – Buy or sell BTC quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now